Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Bassi

Showing results (351-360 of 422) with videos related to

Pageof 43
Sort By:
Frontiers in Nutrition|March 2, 2023
Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: A retrospective, multicenter analysisSalvatore Paiella, Danila Azzolina, Ilaria Trestini, et al.
Updates in Surgery|March 17, 2022
Bioethics in an oncological surgery unit during the COVID-19 pandemic: the Verona experienceMassimiliano Tuveri, Claudio Bassi, Alessandro Esposito, et al.
Annals of Surgery|December 1, 2017
The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume InstitutionLuca Landoni, Giovanni Marchegiani, Tommaso Pollini, et al.
Scientific Reports|July 22, 2021
Gα15 in early onset of pancreatic ductal adenocarcinomaGiulio Innamorati, Thomas M Wilkie, Giorgio Malpeli, et al.
JAMA Surgery|May 26, 2018
Association Between Changes in Body Composition and Neoadjuvant Treatment for Pancreatic CancerMarta Sandini, Manuel Patino, Cristina R Ferrone, et al.
Oncogene|August 13, 2022
Loss of FGFR4 promotes the malignant phenotype of PDACSabrina D'Agosto, Francesco Pezzini, Lisa Veghini, et al.
European Journal of Cancer (Oxford, England : 1990)|November 23, 2023
Perioperative NALIRIFOX in patients with resectable pancreatic ductal adenocarcinoma: The open-label, multicenter, phase II nITRO trialDavide Melisi, Camilla Zecchetto, Valeria Merz, et al.
Surgery|July 26, 2014
Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS)Johanna A M G Tol, Dirk J Gouma, Claudio Bassi, et al.
Annals of Surgery|December 21, 2017
Core Set of Patient-reported Outcomes in Pancreatic Cancer (COPRAC): An International Delphi Study Among Patients and Health Care ProvidersLennart B van Rijssen, Arja Gerritsen, Inge Henselmans, et al.
Annals of Surgery|October 20, 2018
Genetic Analysis of Small Well-differentiated Pancreatic Neuroendocrine Tumors Identifies Subgroups With Differing Risks of Liver MetastasesAntonio Pea, Jun Yu, Luigi Marchionni, et al.
Pageof 43

Showing results (351-360 of 422) with videos related to

Sort By:
Pageof 43
Frontiers in Nutrition|March 2, 2023
Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: A retrospective, multicenter analysisSalvatore Paiella, Danila Azzolina, Ilaria Trestini, et al.
Updates in Surgery|March 17, 2022
Bioethics in an oncological surgery unit during the COVID-19 pandemic: the Verona experienceMassimiliano Tuveri, Claudio Bassi, Alessandro Esposito, et al.
Annals of Surgery|December 1, 2017
The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume InstitutionLuca Landoni, Giovanni Marchegiani, Tommaso Pollini, et al.
Scientific Reports|July 22, 2021
Gα15 in early onset of pancreatic ductal adenocarcinomaGiulio Innamorati, Thomas M Wilkie, Giorgio Malpeli, et al.
JAMA Surgery|May 26, 2018
Association Between Changes in Body Composition and Neoadjuvant Treatment for Pancreatic CancerMarta Sandini, Manuel Patino, Cristina R Ferrone, et al.
Oncogene|August 13, 2022
Loss of FGFR4 promotes the malignant phenotype of PDACSabrina D'Agosto, Francesco Pezzini, Lisa Veghini, et al.
European Journal of Cancer (Oxford, England : 1990)|November 23, 2023
Perioperative NALIRIFOX in patients with resectable pancreatic ductal adenocarcinoma: The open-label, multicenter, phase II nITRO trialDavide Melisi, Camilla Zecchetto, Valeria Merz, et al.
Surgery|July 26, 2014
Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS)Johanna A M G Tol, Dirk J Gouma, Claudio Bassi, et al.
Annals of Surgery|December 21, 2017
Core Set of Patient-reported Outcomes in Pancreatic Cancer (COPRAC): An International Delphi Study Among Patients and Health Care ProvidersLennart B van Rijssen, Arja Gerritsen, Inge Henselmans, et al.
Annals of Surgery|October 20, 2018
Genetic Analysis of Small Well-differentiated Pancreatic Neuroendocrine Tumors Identifies Subgroups With Differing Risks of Liver MetastasesAntonio Pea, Jun Yu, Luigi Marchionni, et al.
Pageof 43